To analyse the safety and efficacy of Thulium laser en bloc enucleation of bladder tumour (ThuLEBT) in comparison to transurethral resection of bladder tumour (TURBT) for treatment of non-muscle invasive bladder cancer (NMIBC).
Methods:
Prospective observational study involving 30 patients in each group of ThuLEBT and TURBT admitted in tertiary care centre from 1st January 2021 to December 2021.
Results:
Significant difference was found in terms of less operative time (p-0.01468), less intraoperative blood loss, a lower incidence of obturator nerve reflex (p-0.00006), bladder perforation (p-0.0455) and bladder irrigation (p-0.0027), better acquisition of detrusor muscle (p-0.0466), less recurrence rate (p-0.0455) in favour of ThuLEBT over TURBT group. The analysis also demonstrated faster postoperative recovery in terms of the duration of catheterisation, bladder irrigation and hospitalisation time in ThuLEBT group.
Conclusions:
ThuLEBT is an efficient and safe treatment for non-muscle invasive bladder cancer and it can be a better alternative choice in place of TURBT.
FerlayJRandiGBosettiC, et al. Declining mortality from bladder cancer in Europe. BJU Int2008; 101: 11–19.
2.
CompératELarréSRoupretM, et al. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch2015; 466: 589–594.
3.
GreggJRMcCormickBWangL, et al. Short term complications from transurethral resection of bladder tumor. Can J Urol2016; 23: 8198–8203.
4.
ShahNFSofiKPNengrooSH.Obturator nerve block in transurethral resection of bladder tumor: a comparison of ultrasound-guided technique versus ultrasound with nerve stimulation technique. Anesth Essays Res2017; 11: 411–415.
5.
GuoCCAl-AhmadieHAFlaigTW, et al. Contribution of bladder cancer pathology assessment in planning clinical trials. Urol Oncol Semin Original Investig2021; 39: 713–719.
6.
KoieTOhyamaCHosogoeS, et al. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer. Int Urol Nephrol2015; 47: 1509–1514.
7.
DalbagniG.Editorial comment on: detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol2010; 57: 849.
8.
BachTNetschCHaeckerA, et al. Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol2010; 28: 39–43.
9.
WoltersMKramerMWBeckerJU, et al. Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol2011; 29: 429–432.
10.
MariappanPZachouAGrigorKM.Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol2010; 57: 843–849.
11.
De NunzioCFrancoGCindoloL, et al. Transuretral resection of the bladder (TURB): analysis of complications using a modified Clavien system in an Italian real life cohort. Eur J Surg Oncol2014; 40: 90–95.
12.
ColladoAChéchileGESalvadorJ, et al. Early complications of endoscopic treatment for superficial bladder tumors. J Urol2000; 164: 1529–1532.
XishuangSDeyongYXiangyuC, et al. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol2010; 24: 69–73.
15.
MigliariRBuffardiAGhabinH.Thulium laser endoscopic en bloc enucleation of nonmuscle-invasive bladder cancer. J Endourol2015; 29: 1258–1262.
16.
LiuHWuJXueS, et al. Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer. Int J Med Res2013; 41: 984–992.
17.
AkandMMuilwijkTRaskinY, et al. Quality control indicators for transurethral resection of non–muscle-invasive bladder cancer. Clin Genitourin Cancer2019; 17: e784–e792.
18.
KramerMWRassweilerJJKleinJ, et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol2015; 33: 1937–1943.
19.
RinkMDahlemRKluthL, et al. Older patients suffer from adverse histopathological features after radical cystectomy. Int J Urol2011; 18: 576–584.
20.
Dołowy KrajewskiWDembowskiJ, et al. The role of lasers in modern urology. Cent Eur J Urol2015; 68: 175.
21.
KramerMWWoltersMCashH, et al. Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014. World J Urol2015; 33: 571–579.
22.
ZhongCGuoSTangY, et al. Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience. World J Urol2010; 28: 157–161.
23.
GendyRDelpradoWBrennerP, et al. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series. BJU Int2016; 117: 54–59.
